Mar 26, 2026Kidney HealthSGLT2 Inhibitors Protect Kidneys Beyond DiabetesSGLT2 inhibitors cut CKD progression by 37% in major trials, including people without diabetes. What the evidence supports—and what remains uncertain.sglt2 inhibitorskidney diseaserenal protectioncardiovascular healthRead article →
Mar 23, 2026NutritionFiber Lowers Two Uremic Toxins in CKD—But Outcomes UnknownA 21-trial review found fiber lowered indoxyl sulfate and p-cresyl sulfate in CKD, while a small resveratrol trial found no effect.dietary fiberkidney diseasegut microbiomeuremic toxinsRead article →
Mar 21, 2026PharmacologySemaglutide Works Broadly. Can GLP1R Genes Predict Response?Semaglutide improves weight, glucose, and cardiovascular outcomes. A small 2025 study links GLP1R genetics to response, but testing is premature.semaglutideglp-1 agonistweight losscardiovascular healthRead article →